• Health & Medicine

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services. There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

2 February 2021

• Health & Medicine
• Policy & Insight

Opinion: 'Beating cancer means beating it for everyone'

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell. We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

29 January 2021

• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Health & Medicine

Bowel scope screening to stop in England

Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster. Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster.

14 January 2021

• Science & Technology
• Policy & Insight

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Health & Medicine

86% of Teens Exposed to Junk Food Ads on Social Media

Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers

18 December 2020

• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Policy & Insight

Beating cancer by improving the public’s health: the road ahead in England

Public Health England could be disbanded by March 2021. Here's what's at stake for cancer. Public Health England could be disbanded by March 2021. Here's what's at stake for cancer.

4 December 2020

• Policy & Insight

Spending Review 2020: Steps in the right direction, but opportunities missed

Today, the Chancellor set out the UK Government’s spending priorities for the next year. Here’s what was announced today and what it could mean for cancer. Today, the Chancellor set out the UK Government’s spending priorities for the next year. Here’s what was announced today and what it could mean for cancer.

25 November 2020

• Health & Medicine

COVID-19 referral drop fears for lung cancer patients in Wales

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

20 November 2020